{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:20:55Z","timestamp":1787062855802,"version":"build-2736575974"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ebm-journal.org"],"crossmark-restriction":true},"short-container-title":["Exp. Biol. Med."],"abstract":"<jats:p>HIV-associated neurocognitive disorders (HAND) persist in up to 50% of people living with HIV (PLWH) despite effective antiretroviral therapy (ART), driven by chronic neuroinflammation, oxidative stress, and neuronal damage. This study investigates the therapeutic potential of combining elvitegravir (EVG), an integrase strand transfer inhibitor, with curcumin (CUR), a natural polyphenol with anti-inflammatory and antioxidant properties, in a murine EcoHIV model of HAND. EcoHIV-infected mice were treated with EVG, CUR, or their combination (EVG + CUR), and cognitive, motor, and molecular outcomes were evaluated. Behavioral assays revealed that EcoHIV infection significantly impaired non-spatial working memory, spatial learning, and motor performance, as assessed by the Novel Object Recognition (NOR)and Morris water Maize (MWM) tests and CatWalk gait analysis. While EVG or CUR alone showed modest improvements, the EVG + CUR combination significantly restored cognitive function, reduced escape latencies in the MWM, and improved motor performance, including gait stability and interlimb coordination. At the molecular level, EVG + CUR treatment attenuated neuroinflammation by reducing pro-inflammatory cytokines (IL-6, TNF-\u03b1, IL-1\u03b2) and chemokine (MCP-1) in the brain and plasma, particularly following intranasal administration. Additionally, EVG + CUR significantly reduced oxidative DNA damage and preserved neuronal integrity without disrupting CNS homeostasis. These findings demonstrate that the EVG + CUR combination effectively targets both viral persistence and the underlying neuroinflammatory and oxidative mechanisms driving HAND. By improving cognitive and motor function while mitigating neuroinflammation and oxidative stress, EVG + CUR represents a promising adjunctive therapy for HAND, offering a multifaceted approach to addressing the complex pathophysiology of HIV-associated neurocognitive disorders.<\/jats:p>","DOI":"10.3389\/ebm.2025.10758","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:10:19Z","timestamp":1762495819000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Curcumin-enhanced elvitegravir therapy mitigates neuroinflammation and cognitive deficits in EcoHIV mice"],"prefix":"10.3389","volume":"250","author":[{"given":"Sandip","family":"Godse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namita","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd","family":"Salman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tauheed","family":"Ishrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"key":"B1","article-title":"AIDS at a crossroads: 2024 global AIDS update","year":"2024"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e2610","DOI":"10.1212\/WNL.0000000000010752","article-title":"Global prevalence and burden of HIV-associated neurocognitive disorder: a meta-analysis","volume":"95","author":"Wang","year":"2020","journal-title":"Neurology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s13365-010-0006-1","article-title":"HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors","volume":"17","author":"Heaton","year":"2011","journal-title":"J Neurovirol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1467175","DOI":"10.3389\/fneur.2025.1467175","article-title":"Decoding HIV-associated neurocognitive disorders: a new perspective from multimodal connectomics","volume":"16","author":"Zhou","year":"2025","journal-title":"Front Neurol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrneurol.2016.27","article-title":"HIV-associated neurocognitive disorder--pathogenesis and prospects for treatment","volume":"12","author":"Saylor","year":"2016","journal-title":"Nat Rev Neurol"},{"key":"B6","first-page":"45","article-title":"Neurologic complications of HIV disease and their treatment","volume":"18","author":"Letendre","year":"2010","journal-title":"Top HIV Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nrn2040","article-title":"HIV and antiretroviral therapy in the brain: neuronal injury and repair","volume":"8","author":"Ellis","year":"2007","journal-title":"Nat Rev Neurosci"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1086\/651277","article-title":"Minocycline attenuates HIV infection and reactivation by suppressing cellular activation in human CD4+ T cells","volume":"201","author":"Szeto","year":"2010","journal-title":"J Infect Dis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1212\/WNL.0b013e31822f0412","article-title":"Minocycline treatment for HIV-associated cognitive impairment: results from a randomized trial","volume":"77","author":"Sacktor","year":"2011","journal-title":"Neurology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"895006","DOI":"10.3389\/fphar.2022.895006","article-title":"Memantine attenuates cocaine and neuroHIV neurotoxicity in the medial prefrontal cortex","volume":"13","author":"Du","year":"2022","journal-title":"Front Pharmacol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1089\/aid.1992.8.209","article-title":"N-acetylcysteine: a new approach to anti-HIV therapy","volume":"8","author":"Roederer","year":"1992","journal-title":"AIDS Res Hum Retroviruses"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1007\/s10787-023-01136-w","article-title":"Curcumin and chemokines: mechanism of action and therapeutic potential in inflammatory diseases","volume":"31","author":"Sadeghi","year":"2023","journal-title":"Inflammopharmacology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1177\/15353702231211863","article-title":"Nanocarrier-mediated curcumin delivery: an adjuvant strategy for CNS disease treatment","volume":"248","author":"Godse","year":"2023","journal-title":"Exp Biol Med (Maywood)"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1021\/acs.jmedchem.6b00975","article-title":"The essential medicinal chemistry of curcumin","volume":"60","author":"Nelson","year":"2017","journal-title":"J Med Chem"},{"key":"B15","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/bs.irn.2023.05.014","article-title":"Nose-to-brain drug delivery for the treatment of CNS disease: new development and strategies","volume":"171","author":"Du","year":"2023","journal-title":"Int Rev Neurobiol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1080\/14656566.2016.1250885","article-title":"Elvitegravir for the treatment of HIV","volume":"17","author":"Unger","year":"2016","journal-title":"Expert Opin Pharmacother"},{"key":"B17","doi-asserted-by":"publisher","first-page":"102368","DOI":"10.1016\/j.xpro.2023.102368","article-title":"Protocol for optimizing production and quality control of infective EcoHIV virions","volume":"4","author":"Alfar","year":"2023","journal-title":"STAR Protoc"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1004985","DOI":"10.3389\/fimmu.2022.1004985","article-title":"Buprenorphine reverses neurocognitive impairment in EcoHIV infected mice: a potential therapy for HIV-NCI","volume":"13","author":"Murphy","year":"2022","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1002\/JLB.5AB0420-531R","article-title":"Treatment with buprenorphine prior to EcoHIV infection of mice prevents the development of neurocognitive impairment","volume":"109","author":"Jaureguiberry-Bravo","year":"2021","journal-title":"J Leukoc Biol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"6857","DOI":"10.1021\/acsanm.4c04637","article-title":"Extracellular vesicle-liposome-darunavir formulation for the treatment of HIV neuropathogenesis","volume":"8","author":"Zhou","year":"2025","journal-title":"ACS Appl Nano Mater"},{"key":"B21","doi-asserted-by":"publisher","first-page":"149256","DOI":"10.1016\/j.brainres.2024.149256","article-title":"A reproducible murine model of studying HIV-associated brain damage in stroke","volume":"1846","author":"Salman","year":"2025","journal-title":"Brain Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"105423","DOI":"10.1016\/j.neuint.2022.105423","article-title":"Verapamil inhibits TXNIP-NLRP3 inflammasome activation and preserves functional recovery after intracerebral hemorrhage in mice","volume":"161","author":"Ismael","year":"2022","journal-title":"Neurochem Int"},{"key":"B23","doi-asserted-by":"publisher","first-page":"19864","DOI":"10.1038\/s41598-023-47226-1","article-title":"Curcumin enhances elvitegravir concentration and alleviates oxidative stress and inflammatory response","volume":"13","author":"Godse","year":"2023","journal-title":"Sci Rep"},{"key":"B24","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3390\/brainsci15040328","article-title":"PLGA-encapsulated elvitegravir and curcumin modulates ART penetration, oxidative stress, and inflammation","volume":"15","author":"Godse","year":"2025","journal-title":"Brain Sci"},{"key":"B25","doi-asserted-by":"publisher","first-page":"100054","DOI":"10.1016\/j.bbih.2020.100054","article-title":"Prevention and treatment of HIV infection and cognitive disease in mice by innate immune responses","volume":"3","author":"Dong","year":"2020","journal-title":"Brain Behav and Immun - Health"},{"key":"B26","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.bbi.2016.01.020","article-title":"Expression of gp120 in mice evokes anxiety behavior: co-occurrence with increased dendritic spines and brain-derived neurotrophic factor in the amygdala","volume":"54","author":"Bachis","year":"2016","journal-title":"Brain Behav Immun"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.89837","article-title":"Persistence of intact HIV-1 proviruses in the brain during antiretroviral therapy","volume":"12","author":"Sun","year":"2023","journal-title":"Elife"},{"key":"B28","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1097\/QAI.0000000000002314","article-title":"Cognition, structural brain changes, and systemic inflammation in adolescents living with HIV on antiretroviral therapy","volume":"84","author":"Hoare","year":"2020","journal-title":"JAIDS J Acquired Immune Deficiency Syndromes"},{"key":"B29","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1310\/hct1101-59","article-title":"Memantine for AIDS dementia complex: open-label report of ACTG 301","volume":"11","author":"Zhao","year":"2010","journal-title":"HIV Clin Trials"},{"key":"B30","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1177\/026988110001400304","article-title":"HIV dementia: the role of the basal ganglia and dopaminergic systems","volume":"14","author":"Berger","year":"2000","journal-title":"J Psychopharmacol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1007\/s00415-017-8503-2","article-title":"HIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment","volume":"264","author":"Eggers","year":"2017","journal-title":"J Neurol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"4697","DOI":"10.3390\/ijms25094697","article-title":"HIV-associated neurocognitive disorder: a look into cellular and molecular pathology","volume":"25","author":"Thompson","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e0261605","DOI":"10.1371\/journal.pone.0261605","article-title":"HIV testing and ART initiation among partners, family members, and high-risk associates of index clients participating in the CommLink linkage case management program, Eswatini, 2016-2018","volume":"16","author":"Williams","year":"2021","journal-title":"PLoS One"},{"key":"B34","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/07853890.2020.1814962","article-title":"Important role of microglia in HIV-1 associated neurocognitive disorders and the molecular pathways implicated in its pathogenesis","volume":"53","author":"Borrajo","year":"2021","journal-title":"Ann Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1093\/cid\/ciw697","article-title":"Very early ART and persistent inflammation in treated HIV","volume":"64","author":"Hunt","year":"2017","journal-title":"Clin Infect Dis"},{"key":"B36","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1208\/s12248-012-9432-8","article-title":"Therapeutic roles of curcumin: lessons learned from clinical trials","volume":"15","author":"Gupta","year":"2013","journal-title":"AAPS J"},{"key":"B37","doi-asserted-by":"publisher","first-page":"111119","DOI":"10.1016\/j.biopha.2020.111119","article-title":"The role of curcumin in aging and senescence: molecular mechanisms","volume":"134","author":"Zia","year":"2021","journal-title":"Biomed and Pharmacother"},{"key":"B38","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3390\/biomedicines11010159","article-title":"The many faces of immune activation in HIV-1 infection: a multifactorial interconnection","volume":"11","author":"Mazzuti","year":"2023","journal-title":"Biomedicines"},{"key":"B39","doi-asserted-by":"publisher","first-page":"H1","DOI":"10.1530\/VB-19-0033","article-title":"Immune cell trafficking across the blood-brain barrier in the absence and presence of neuroinflammation","volume":"2","author":"Marchetti","year":"2020","journal-title":"Vasc Biol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"805657","DOI":"10.3389\/fimmu.2022.805657","article-title":"How does the immune system enter the brain?","volume":"13","author":"Mapunda","year":"2022","journal-title":"Front Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.nbd.2009.07.031","article-title":"The blood-brain barrier and immune function and dysfunction","volume":"37","author":"Banks","year":"2010","journal-title":"Neurobiol Dis"},{"key":"B42","doi-asserted-by":"publisher","first-page":"14988","DOI":"10.3390\/ijms232314988","article-title":"Quality of T-Cell response to SARS-CoV-2 mRNA vaccine in ART-treated PLWH","volume":"23","author":"Tortellini","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B43","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s11906-019-0956-5","article-title":"Patho-immune mechanisms of hypertension in HIV: a systematic and thematic review","volume":"21","author":"Masenga","year":"2019","journal-title":"Curr Hypertens Rep"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.3390\/ijms25052621","article-title":"HIV reservoirs and treatment strategies toward curing HIV infection","volume":"25","author":"Matsuda","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1097\/QAD.0000000000001836","article-title":"Reversing interferon-alpha neurotoxicity in a HIV-associated neurocognitive disorder mouse model","volume":"32","author":"Koneru","year":"2018","journal-title":"AIDS"},{"key":"B46","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s13365-014-0258-2","article-title":"Glutamate metabolism and HIV-associated neurocognitive disorders","volume":"20","author":"Vazquez-Santiago","year":"2014","journal-title":"J Neurovirol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1007\/s11481-013-9442-z","article-title":"Targeting the glutamatergic system for the treatment of HIV-associated neurocognitive disorders","volume":"8","author":"Potter","year":"2013","journal-title":"J Neuroimmune Pharmacol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"100235","DOI":"10.1016\/j.bbih.2021.100235","article-title":"The role of oxidative stress in HIV-associated neurocognitive disorders","volume":"13","author":"Buckley","year":"2021","journal-title":"Brain Behav and Immun - Health"},{"key":"B49","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/10934529.2023.2185004","article-title":"Heavy metals and inflammatory, oxidative\/antioxidant and DNA damage biomarkers among people living with HIV\/AIDS (PLWHA) in Niger Delta, Nigeria","volume":"58","author":"Folorunso","year":"2023","journal-title":"J Environ Sci Health A"},{"key":"B50","doi-asserted-by":"publisher","first-page":"18929","DOI":"10.1038\/srep18929","article-title":"HIV-1 gp120 induces type-1 programmed cell death through ER stress employing IRE1\u03b1, JNK and AP-1 pathway","volume":"6","author":"Shah","year":"2016","journal-title":"Sci Rep"},{"key":"B51","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s13365-019-00737-y","article-title":"HIV-associated neurodegeneration: exploitation of the neuronal cytoskeleton","volume":"25","author":"Wenzel","year":"2019","journal-title":"J Neurovirol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1007\/s13365-019-00728-z","article-title":"Pathogenesis of age-related HIV neurodegeneration","volume":"25","author":"Mackiewicz","year":"2019","journal-title":"J Neurovirol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"5123","DOI":"10.3390\/ijms25105123","article-title":"Curcumin improves neurogenesis in alzheimer\u2019s disease mice via the upregulation of Wnt\/\u03b2-Catenin and BDNF","volume":"25","author":"Lou","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B54","doi-asserted-by":"publisher","first-page":"4196","DOI":"10.2174\/0929867322666151029104611","article-title":"Curcumin: a natural lead for potential new drug candidates","volume":"22","author":"Oliveira","year":"2015","journal-title":"Curr Med Chem"},{"key":"B55","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/s11095-008-9735-8","article-title":"Curcumin inhibits the activity of ABCG2\/BCRP1, a multidrug resistance-linked ABC drug transporter in mice","volume":"26","author":"Shukla","year":"2009","journal-title":"Pharm Res"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1292807","DOI":"10.3389\/fphar.2024.1292807","article-title":"Natural products for the treatment of chemotherapy-related cognitive impairment and prospects of nose-to-brain drug delivery","volume":"15","author":"He","year":"2024","journal-title":"Front Pharmacol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"115196","DOI":"10.1016\/j.addr.2024.115196","article-title":"Intranasal drug delivery: the interaction between nanoparticles and the nose-to-brain pathway","volume":"207","author":"Chen","year":"2024","journal-title":"Adv Drug Deliv Rev"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.3390\/pharmaceutics12121230","article-title":"Intranasal nanoemulsions for direct nose-to-brain delivery of actives for CNS disorders","volume":"12","author":"Bahadur","year":"2020","journal-title":"Pharmaceutics"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.2147\/IJN.S439181","article-title":"Recent advances in intranasal administration for brain-targeting delivery: a comprehensive review of lipid-based nanoparticles and stimuli-responsive gel formulations","volume":"19","author":"Koo","year":"2024","journal-title":"Int J Nanomedicine"}],"container-title":["Experimental Biology and Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.ebm-journal.org\/articles\/10.3389\/ebm.2025.10758\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:10:21Z","timestamp":1762495821000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ebm-journal.org\/articles\/10.3389\/ebm.2025.10758\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":59,"alternative-id":["10.3389\/ebm.2025.10758"],"URL":"https:\/\/doi.org\/10.3389\/ebm.2025.10758","relation":{},"ISSN":["1535-3699"],"issn-type":[{"value":"1535-3699","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,7]]},"article-number":"10758"}}